Company profile: MicroTransponder
1.1 - Company Overview
Company description
- Provider of neurostimulation medical devices and therapies to treat neurological diseases, including the Vivistim Paired VNS System for post-stroke arm and hand motor recovery, the Serenity System for tinnitus, and the Model 1001 implantable vagus nerve lead. Offers neurostimulation approaches for PTSD, obsessive disorders, phobias, addiction, and motor function improvement.
Products and services
- Model 1001 lead: An implantable-grade vagus nerve lead used within the Vivistim System, architected for neurostimulation applications and applicable across other therapies targeting vagus nerve stimulation
- Serenity System: A neurostimulation-based tinnitus therapy system, developed to treat tinnitus via device-driven neural stimulation
- Vivistim Paired VNS System: A paired-VNS neurostimulation product for post-stroke arm and hand motor function recovery, integrating vagus nerve stimulation with physical therapy.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to MicroTransponder
Stellate
HQ: Canada
Website
- Description: Provider of networking, database, recording, review, and analysis systems for electrical activity from the brain, serving EEG laboratories, epilepsy monitoring units, sleep laboratories, and intensive care units; engaged in the development, design, and manufacture of products for brain activity recording and analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Stellate company profile →
Cervel Neurotech
HQ: United States
Website
- Description: Provider of medical device solutions for non-invasive deep brain neuro-modulation, pioneering an innovative, proprietary approach based on repetitive transcranial magnetic stimulation (rTMS).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cervel Neurotech company profile →
Annovis Bio
HQ: United States
Website
- Description: Provider of treatments for Alzheimer’s, Parkinson’s, and other neurodegenerative disorders, including: Buntanetap, an oral small molecule inhibiting multiple neurotoxic proteins; ANVS405, an IV formulation for acute neurodegeneration like TBI and stroke; and ANVS301, a Phase 1 compound aiming to increase cognitive capabilities in later-stage Alzheimer’s and dementia.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Annovis Bio company profile →
Orexo
HQ: Sweden
Website
- Description: Provider of pharmaceutical treatments and drug delivery technologies, including Zubsolv, a medication for opioid dependence commercialized in the US, and AmorphOX, a proprietary nasal delivery technology used to develop new pharmaceutical products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Orexo company profile →
Spiegelberg
HQ: Germany
Website
- Description: Provider of catheters and probes for neurosurgical use in the brain, as well as antimicrobial products to prevent hospital-acquired infections; began operation in 1986 and is headquartered in Hamburg, Germany.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Spiegelberg company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for MicroTransponder
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to MicroTransponder
2.2 - Growth funds investing in similar companies to MicroTransponder
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for MicroTransponder
4.2 - Public trading comparable groups for MicroTransponder
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →